HealthTech

ApexEngine

ApexEngine Raises $30M Series B to Transform HealthTech

$30M Series B
Total Raised
Series
Latest Round
2022
Founded
100-250
Employees
Seattle, WA
1 min read

Quick Facts

Valuation
$350M
Latest Round Size
$30M Series B
Latest Round Date
October 2025

ApexEngine Raises $30M Series B in Latest Funding Round

ApexEngine has successfully closed a $30M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by Tiger Global, with participation from Sequoia Capital.

Company Overview

Founded in 2022 and headquartered in Seattle, WA, ApexEngine has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI

With a current valuation of $350M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $30M Series B
  • Valuation: $350M
  • Lead Investor: Tiger Global

Future Outlook

As ApexEngine moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Tiger Global
Venture Capital
Leading venture capital firm investing in technology companies
Sequoia Capital
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Emma Rodriguez
Emma Rodriguez
Senior venture capital analyst with 8+ years covering Series A to growth-stage investments across fintech and AI sectors.